SpaceX has filed confidentially for IPO ahead of AI rivals

SpaceX filed a confidential draft IPO with the SEC targeting a possible June listing and a potential valuation above $1.75 trillion, with reported proceeds up to $75 billion. The company recently acquired xAI (previous combined valuation $1.25 trillion) and expects core revenues from launches and Starlink to approach ~$20 billion in 2026 while xAI is forecast to generate under $1 billion. Major banks including BofA, Citi, Goldman, JPMorgan and Morgan Stanley are in senior roles, international banks have been lined up, and SpaceX is considering a dual-class share structure and allocating as much as 30% of the offering to retail, with investor briefings planned.

Analysis

The most direct, underappreciated beneficiary is not fee income alone but aftermarket trading and prime-broker flow that follows a mega-IPO. If the deal clears, underwriting fees (typically 1–2% of proceeds) are a headline number, but the larger multi-quarter profit pool is margin from increased retail trading, stabilisation activity and incremental prime financing to hedge funds looking to trade the float; that favors US bulge-bracket prime brokers with large retail franchises and balance-sheet capacity. Expect concentrated revenue recognition in the next 6–12 months and a measurable bump to IB and FICC P&L items that are easier to miss in quarterly guidance but visible in annualized revenue run-rates.

A large retail allocation materially shifts who captures the upside: banks with deep retail channels and custody/clearing scale win both order flow and float. That amplifies small-deposit inflows and non-interest income (commissions, margin, payment flows) over 3–9 months, while regional and international banks tasked with locale distribution capture fee revenue with little balance-sheet uplift. Conversely, banks heavily relied on capital markets inventory models or with weaker retail footprints will see a smaller step-change.

Key risks are timing and valuation — a pulled or repriced deal would reverse sentiment quickly and create reputational losses for lead managers, compressing IB multiples across the sector within days. Lock-up expiries (6–12 months) and any early aftermarket weakness pose second-order funding/rehypothecation stress for prime desks. Regulatory scrutiny of dual-class structures or cross-border allocation mechanics could add execution risk and delay fee recognition.

Practical signal: watch underwriters’ updated guidance and retail allocation disclosures during the roadshow window — changes there will move relative bank trading flows more than headline fee estimates. Also monitor prime financing spreads and margin loans at GS/MS/JPM as a leading indicator of hedge-fund positioning into the float.

Key Decisions for Investors

• Overweight GS and MS (equal-weight, tactical) for 3–6 months to capture prime-broker and IB upside; target +12–18% outperformance if the deal completes and retail flow materializes. Position size: 3–5% of equity book each. Stop-loss: 8% absolute. Rationale: highest operating leverage to underwriting plus recurring prime financing.
• Pair trade — Long BAC / Short BCS (dollar-neutral) for 3–6 months. Expect BAC to benefit from incremental retail/clearing flow and deposits while Barclays bears regional FX and execution risk. Target R/R ~2:1 (target return 10–15%, max loss 5–7%).
• Buy a call spread on JPM: Buy 6-month 5–7% OTM calls and sell 20–25% OTM calls (risk-defined, limited debit) to harvest a 6–12 month earnings re-rate from deal-related trading and custody flows. Allocate 1–2% of options allocation; exit if JPM revises IB guidance down or if broad market volatility spikes.
• If you prefer lower-beta exposure, buy small position in RY or MFG (3–6 month horizon) to capture international placement fees with less US equity-market sensitivity. Keep size modest (1–2%) given lower per-ticker upside and currency/regulatory tail risks.